Two guidelines completed by the Breast Department of Henan Cancer Hospital were evaluated by the Star Guide

Recently, the rating of the Chinese Guide/Consensus STAR in 2021 was announced. Two guidelines completed by the breast team of our hospital "Clinical Practical Practical Guidelines for Multi -Gene Detectives of early breast cancer patients" and "Breast Cancer Reconstruction Treatment Clinical Practice Guide", "Guidelines for Breast cancer" It performed well in this rating, ranking among the top 20%(54th) and top 30%(86th) of 291 guidelines.

In order to better promote the development of my country's clinical guidelines/consensus, and make every effort to solve the issues such as splitting and evaluation dimensions from the current guidelines to the implementation of the implementation process. With the support of the Chinese Medical Association magazine and other institutions, 106 clinical medical workers, methodologists and journal editors from 34 majors across the country have developed science, transparency, and applicability (transparency), transparet, and application. ) Rankings (Rankings) guide rating tool, referred to as "Star".

In February 2022, the rating of the Chinese Guide/Consensus STAR, which was officially published in the 2021 medical journal and the 291 guidelines and 858 consensus led by Chinese experts, to help clinicians effectively select and use high -quality high quality Guidelines/consensus, promote the improvement of the quality of Chinese guidelines/consensus, and let more Chinese consensus on the international stage.

Two guidelines follow the World Health Organization Guide to formulate manual standards, and under the collaboration of the Development Committee of the Breast Surgery Group of the Chinese Medical Association's Surgery Branch, the Literature Research Committee, and the Standardous Committee of the Evidence Standard, Voting, writing manuscripts, repair of manuscripts and other links, the writing of the guide is finally completed.

Both guidelines were published in the Chinese Medical Magazine English Edition (CMJ), and it was also part of the "Guide to Clinical Practice of Breast Surgery (2021) of the Chinese Medical Society". This is the first Chinese breast surgery clinical practice guide based on evidence -based medical evidence. It presented scientific and available Chinese breast surgery clinical practice "gold standards" to domestic and foreign breast surgery!

my country's first evidence -based medical guide on breast cancer multi -gene testing

Breast cancer has become one of the most incidence of malignant tumors in the world, and the incidence of breast cancer in China is still rising year by year. In foreign countries, the status of multi -gene testing in patients with early breast cancer has obtained a wide consensus in the formulation of auxiliary chemotherapy decisions. However, the current multi -gene testing research is mainly based on the results of Western people, and multi -gene analysis research on Chinese people is still less.

In order to improve breast tumor professional doctors to reasonably choose multi -gene testing to adapt to witnesses and detection methods, and carefully refer to the results of multi -gene test results to formulate auxiliary treatment decisions, the Breast Surgery Group of the Chinese Medical Society's Surgery Society passed the literature survey and expert discussion, and proposed a multi -gene Test the key clinical issues of clinical practice guidelines, and give meticulous and cautious recommendations.

Based on this, as a member of the Breast Surgery Group of the Chinese Medical Association Surgery Branch, Liu Zhenzhen's team formulated the "Chinese Medical Society's Surgery Surgery Group (CSBRS) early breast cancer multi -gene test clinical practice guidelines (2021 version)" Born, this is also China's first evidence -based medical guide on breast cancer multi -gene testing.

Director Liu Zhenzhen introduced: "For breast cancer multi -gene detection, the results of the Chinese population lacking large samples still lack large samples, and multi -gene detection has uniform and strict testing technical standards. The letter provides important guarantees.

The development level of my country's testing technology is not balanced, and the testing technology needs to be popularized and standardized, and the test results need to be interpreted carefully. The formulation of the Chinese version of breast cancer multi -gene detection guidelines, which provides important reference standards for regulating domestic mammary tumor professional doctors to reasonably choose multi -gene testing to adapt to testimony and detection methods, carefully reference multi -gene test results.

The clinical practice guidelines for the improvement of breast cancer improvement of Chinese national conditions

Early Chinese breast cancer patients received more than 70%of breast resection. Among them, AUCHINCLOSS was the main surgical method for patients with armpit lymph node -positive breast cancer.

In order to regulate the clinical application of the root cause of breast cancer improvement in my country, the learning group organized domestic experts to conduct the theoretical basis and technical details of breast cancer improvement surgery through literature retrieval and expert discussions. The expert group discussed the Auchincloss surgery Positioning, incision design, leather petal free level and range, tissue, surgical techniques, and complications needed during surgery, and the processing of complications.

As a member of the Breast Surgery Group of the Chinese Medical Society of the Chinese Medical Association, Liu Zhenzhen, Director Liu Zhenzhen of the Department of Breast Department of Henan Cancer Hospital, formulated the "Guide to the Practical Guide of the Breast Surgery Group (CSBRS) Breast Cancer Reconstruction Root Treatment of the Chinese Medical Association (2021 version)" Essence

Director Liu Zhenzhen introduced: "In the surgical treatment of breast cancer, the root treatment of breast cancer is one of the commonly used techniques. Improved cure guidelines can help Chinese breast surgeons master the basic concept of breast surgery that is suitable for national conditions. The platform of breast surgeons exchange academic theory to further improve the level of standardized diagnosis and treatment of breast disease in my country. "It is understood that the guide will rely on the" Chinese Breast Disease Specialist Property Enhancement Project "to pass the" standardized diagnosis and treatment of Chinese mammary disease " The online boutique classroom "" Chinese Medical Association Surgery Branch's Second Breast Surgery Annual Conference (China Dalian) "and other academic platforms were promoted. The Chinese version guide is expected to be published by the People's Health Publishing House in September this year.

The Department of Breast Department of Henan Cancer Hospital is a national -level mammary disease diagnosis and treatment standardization and minimally invasive rotation surgery training base. It is a medical and scientific research institution that integrates multi -disciplines such as surgery, chemotherapy, radiotherapy, pathology, and imaging diagnosis. The top 20%and 30%of the "Star" rating guidelines this time are encouragement and spur on the team's team.

In the future, Henan Cancer Hospital will continue to promote the level of transformation and research, further improve the standardized diagnosis and treatment of breast cancer in the province, maximize the provision of safe, efficient and convenient medical services to patients with tumor patients, improve core competitiveness, accelerate the establishment of national tumor comprehensively, Regional Medical Center.

Source: Henan Cancer Hospital

- END -